LINC01232 and colorectal carcinoma: A recent study has shown that LINC01232 interacts with p300 to enhance H3K27ac modifications on the ARNTL2 promoter, which promotes the transcriptional activity of ARNTL2, thereby inhibiting ferroptosis in CRC and promoting the proliferation of CRC cells [149].